Summary
In a randomized double-blind study we evaluated the effects on cervical ripening and labor induction of 0.5 mg PGE2 in gel given intracervically and 2.0 mg PGE2 given as a vaginal suppository. All patients were at term with unfavorable cervical scores. The indications for induction were toxemia, diabetes mellitus, Rh-immunization, or intrauterine growth retardation. Significantly better results for both cervical priming and labor induction were obtained after intracervical PGE2-gel application than after treatment with placebo or vaginal suppositories. Eleven out of 19 patients (58%) were delivered within 24 h after intracervical PGE2-gel compared to two out of 19 patients given placebo (p < 0.01). In patients not delivered 24 h after the start of treatment, the mean cervical score had changed from 3.7 to 6.0 (p < 0.05) after PGE2-gel application compared to a change from 3.9 to 4.3 after placebo treatment (n.s.). The outcome after treatment with PGE2 suppositories did not differ significantly from that with placebo treatment.
In a subsequent study 25 patients were given 0.5 mg PGE2-gel intracervically. The results were consistent with those obtained in patients receiving PGE2-gel intracervically in the double-blind study.
Few side effects were noted. No patient complained of gastro-intestinal discomfort but increased myometrial activity was observed in two patients; one after placebo and the other after active intracervical PGE2-gel treatment. The hyperactivity was readily countered with the β2-agonist, terbutaline. All infants were born in good condition with Apgar scores of 7 or more within 5 min. At pediatric examinations at 1 week and at 6 months of age all children seemed healthy.
Similar content being viewed by others
References
Ulmsten U, Wingerup L (1979) Cervical priming induced by prostaglandin E2 in viscous gel. Acta Obstet Gynecol Scand Suppl 84: 11
Ulmsten U, Wingerup L, Belfrage P (1982) Intracervical application of prostaglandin gel for induction of term labor. Obstet Gynecol 54: 339
Ekman G, Forman A, Marsál K, Ulmsten U (1983) Intravaginal versus intracervical application of prostaglandin E2 in viscous gel for cervical priming and induction of labor at term in patients with an unfavorable cervical state. Am J Obstet Gynecol 147: 657
Ulmsten U, Johansson O, Kirstein-Pedersen A (1979) New gel for intracervical application of prostaglandin E2. Lancet 1: 377
Floberg J, Allen J, Belfrage P, Bygdeman M, Ulmsten U (1983) Experience with an industrially manufactured gel PGE2 for cervical priming. Arch Gynecol 233: 225
Ulmsten U, Wingerup L, Andersson K-E (1979) Comparison of prostaglandin E2 and intravenous oxytocin for induction of labor. Obstet Gynecol 54: 581
Ulmsten U, Ueland K (1983) The forces of labor. Uterine contractions and the resistance of the cervix. Clin Obstet Gynecol 26: 1
Forman A, Ulmsten U, Wingerup L, Banyai J (1982) Effects of intracervical PGE2-gel on myometrial activity and cervical state. Prostaglandins 24: 303
Forman A, Ulmsten U, Banyai J (1982) Evidence for a local effect of intracervical prostaglandin E2 gel. Am J Obstet Gynecol 143: 756
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ulmsten, U., Ekman, G., Belfrage, P. et al. Intracervical versus intravaginal PGE2 for induction of labor at term in patients with an unfavorable cervix. Arch. Gynecol. 236, 243–248 (1985). https://doi.org/10.1007/BF02133942
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02133942